These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36397105)

  • 21. Evidence of reduction of rotavirus diarrheal disease after rotavirus vaccine introduction in national immunization programs in the African countries: Report of the 11
    Mwenda JM; Mandomando I; Jere KC; Cunliffe NA; Duncan Steele A
    Vaccine; 2019 May; 37(23):2975-2981. PubMed ID: 31029514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ORVAC trial: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis: a statistical analysis plan.
    Jones MA; Graves T; Middleton B; Totterdell J; Snelling TL; Marsh JA
    Trials; 2020 Aug; 21(1):741. PubMed ID: 32843086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practices and trends in clinical trial registration in the Pan African Clinical Trials Registry (PACTR): a descriptive analysis of registration data.
    Ndwandwe DE; Runeyi S; Pienaar E; Mathebula L; Hohlfeld A; Wiysonge CS
    BMJ Open; 2022 Jan; 12(1):e057474. PubMed ID: 35078852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19-related research in Africa: a cross-sectional review of the International Clinical Trial Registration Platform (ICTRP).
    Edem B; Williams V; Onwuchekwa C; Umesi A; Calnan M
    Trials; 2021 Oct; 22(1):682. PubMed ID: 34620207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of rotavirus in India--is rotavirus vaccine an answer to it?
    Taneja DK; Malik A
    Indian J Public Health; 2012; 56(1):17-21. PubMed ID: 22684168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of rotavirus infection among children with acute diarrhoea after rotavirus vaccine introduction in Kenya, a hospital cross-sectional study.
    Muendo C; Laving A; Kumar R; Osano B; Egondi T; Njuguna P
    BMC Pediatr; 2018 Oct; 18(1):323. PubMed ID: 30309343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
    Pawinski R; Debrus S; Delem A; Smolenov I; Suryakiran PV; Han HH
    J Infect Dis; 2010 Sep; 202 Suppl():S80-6. PubMed ID: 20684722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.
    Groome MJ; Koen A; Fix A; Page N; Jose L; Madhi SA; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2017 Aug; 17(8):843-853. PubMed ID: 28483414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring qualitative methods reported in registered trials and their yields (EQUITY): systematic review.
    Clement C; Edwards SL; Rapport F; Russell IT; Hutchings HA
    Trials; 2018 Oct; 19(1):589. PubMed ID: 30373646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis.
    Ngabo F; Tate JE; Gatera M; Rugambwa C; Donnen P; Lepage P; Mwenda JM; Binagwaho A; Parashar UD
    Lancet Glob Health; 2016 Feb; 4(2):e129-36. PubMed ID: 26823214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rotavirus diarrhoea hospitalizations among children under 5 years of age in Nigeria, 2011-2016.
    Tagbo BN; Mwenda JM; Eke CB; Edelu BO; Chukwubuike C; Armah G; Seheri ML; Isiaka A; Namadi L; Okafor HU; Ozumba UC; Nnani RO; Okafor V; Njoku R; Odume C; Benjamin-Pujah C; Azubuike C; Umezinne N; Ogude N; Osarogborun VO; Okwesili MU; Ezebilo SK; Udemba O; Yusuf K; Mahmud Z; Ticha JM; Obidike EO; Mphahlele JM;
    Vaccine; 2018 Dec; 36(51):7759-7764. PubMed ID: 29802002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality assessment of clinical trial registration with traditional Chinese medicine in WHO registries.
    Zhang X; Tian R; Yang Z; Zhao C; Yao L; Lau C; Wu T; Shang H; Zhang X; Lu A; Bian Z
    BMJ Open; 2019 Feb; 9(2):e025218. PubMed ID: 30782928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Workshop on intussusception in African countries--meeting report.
    Steele AD; Patel M; Cunliffe NA; Bresee JS; Borgstein E; Parashar UD
    Vaccine; 2012 Apr; 30 Suppl 1():A185-9. PubMed ID: 22520130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh.
    Feller AJ; Zaman K; Lewis KD; Hossain I; Yunus M; Sack DA
    Vaccine; 2012 Apr; 30 Suppl 1():A101-5. PubMed ID: 22520118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of an ideal rotavirus vaccine.
    Reisinger KS; Block SL
    Clin Pediatr (Phila); 2008 Jul; 47(6):555-63. PubMed ID: 18467670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries.
    Simpson E; Wittet S; Bonilla J; Gamazina K; Cooley L; Winkler JL
    BMC Public Health; 2007 Oct; 7():281. PubMed ID: 17919334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of rotavirus vaccines.
    Wang CM; Chen SC; Chen KT
    World J Pediatr; 2015 Nov; 11(4):300-8. PubMed ID: 26454434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
    Groome MJ; Fairlie L; Morrison J; Fix A; Koen A; Masenya M; Jose L; Madhi SA; Page N; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2020 Jul; 20(7):851-863. PubMed ID: 32251641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines.
    Chandran A; Fitzwater S; Zhen A; Santosham M
    Biologics; 2010 Aug; 4():213-29. PubMed ID: 20714358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.